Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland (original) (raw)

Risk assessment of trisomy 21 by maternal age and fetal nuchal translucency thickness in 7096 unselected pregnancies in Slovenia

ksenija gersak

Journal of Perinatal Medicine, 2008

View PDFchevron_right

Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise between Sensitivity and Specificity

Tsolmon Boldoo

Central Asian Journal of Medical Sciences

View PDFchevron_right

Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness

Stefano Faiola

Ultrasound in Obstetrics and Gynecology, 2005

View PDFchevron_right

Relation Between Increased Fetal Nuchal Translucency Thickness and Chromosomal Defects

K. Avgidou

Obstetrics & Gynecology, 2006

View PDFchevron_right

Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?

Mar Bennasar

Ultrasound in Obstetrics & Gynecology, 2014

View PDFchevron_right

First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies

rdeci knof

Genetics and Etiology of Down Syndrome, 2011

View PDFchevron_right

Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21

Adolfo Etchegaray

Ultrasound in Obstetrics and Gynecology, 2009

View PDFchevron_right

Screening for Trisomy 21 with Maternal Age, Fetal Nuchal Translucency and Maternal Serum Biochemistry at 11–14 Weeks: A Regional Experience from Germany

Alexander Scharf

Fetal Diagnosis and Therapy, 2006

View PDFchevron_right

Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?

Monica Echevarria

Obstetrics & Gynecology, 2002

View PDFchevron_right

Characteristics and outcome of fetal nuchal translucency above 3.5 mm in the fi rst trimester

Cátia Lourenço

Open Journal of Biological Sciences, 2019

View PDFchevron_right

First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population

Geeta Sharma

Ultrasound in Obstetrics and Gynecology, 2003

View PDFchevron_right

First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations

Shanthi Sairam, Baskaran Thilaganathan, Federico Prefumo

American Journal of Obstetrics and Gynecology, 2006

View PDFchevron_right

Pregnancy outcome in fetuses with increased nuchal translucency

murat yayla

Journal of Perinatology, 2008

View PDFchevron_right

Nuchal Translucency Measurement Did Not Significantly Predict Trisomy Cases in Tertiary Referral Center

Ajlan Tukun

2012

View PDFchevron_right

Nuchal Translucency in Normal Fetus and Its Variation With Increasing Crown Rump Length (Crl) and Gestational Age

Kishor Khanal

Kathmandu University Medical Journal, 2015

View PDFchevron_right

One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies

Renu Bindra

Ultrasound in Obstetrics and Gynecology, 2002

View PDFchevron_right

Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21

Elena Casals

Ultrasound in Obstetrics and Gynecology, 2007

View PDFchevron_right

Delta‐NT or NT MoM: which is the most appropriate method for calculating accurate patient‐specific risks for trisomy 21 in the first trimester?

Renu Bindra

Ultrasound in Obstetrics & Gynecology, 2003

View PDFchevron_right

Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester

Christoph Berg

Ultrasound in Obstetrics and Gynecology, 2010

View PDFchevron_right

Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol

Annie Vereecken

Prenatal Diagnosis, 2005

View PDFchevron_right

Variaton of nuchal translucency with increasing crown rump length and gestational age in normal singleton pregnancies

IOSR Journals

View PDFchevron_right

Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free hCG and pregnancy-associated plasma protein-A

catalina valencia

Human Reproduction, 2008

View PDFchevron_right

Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free b-hCG and pregnancy-associated plasma protein-A

catalina valencia

2000

View PDFchevron_right

Nuchal translucency: an ultrasound marker for fetal chromosomal abnormalities

Gregório Acacio

Sao Paulo Medical Journal, 2001

View PDFchevron_right

The significance of fetal maxillary length in the first trimester screening for trisomy 21

mine kanat-pektas

Archives of Gynecology and Obstetrics, 2011

View PDFchevron_right

P31.04: Nuchal translucency for aneuploidies: single center experience in Brazil

LILIAN CRISTINA L C M F MONTEIRO FRANÇA

Ultrasound in Obstetrics and Gynecology, 2007

View PDFchevron_right

Minor sonographic signs of trisomy 21 at 15–20 weeks' gestation in fetuses born without malformations: a prospective study

A. Sciarrone, E. Viora

2001

View PDFchevron_right

722: Follow-up frequency of testing in patients at very low risk for Trisomy 21 on first trimester screening

Peter Benn

American Journal of Obstetrics and Gynecology, 2012

View PDFchevron_right

Combining nuchal translucency with umbilical Doppler velocimetry for detecting fetal trisomies in the first trimester of pregnancy

Antoni Borrell

BJOG: An International Journal of Obstetrics and Gynaecology, 1997

View PDFchevron_right